Hitoshi Ban

Title: Hitoshi Ban: Innovator in Tyrosine Bioconjugation

Introduction

Hitoshi Ban is a prominent inventor based in Atagoyama, Japan. He has made significant contributions to the field of bioconjugation, particularly through his innovative work on tyrosine ligation reactions. His research has opened new avenues for the modification of small molecules, peptides, and proteins.

Latest Patents

Hitoshi Ban holds a patent for "Tyrosine bioconjugation through aqueous Ene-like reactions." This patent describes a new and versatile class of cyclic diazodicarboxamides that react efficiently and selectively with phenols and the phenolic side chain of tyrosine. The mild aqueous tyrosine ligation reaction operates over a broad pH range, expanding the repertoire of aqueous chemistries available for various modifications. The reactions are compatible with the labeling of native enzymes and antibodies in buffered aqueous solutions. This novel synthetic approach to bispecific antibodies is expected to find broad utility in peptide and protein chemistry, as well as in the chemistry of phenol-containing compounds.

Career Highlights

Hitoshi Ban is affiliated with The Scripps Research Institute, where he continues to advance his research in bioconjugation. His work has garnered attention for its potential applications in therapeutic development and protein engineering.

Collaborations

Hitoshi Ban has collaborated with notable colleagues, including Carlos F Barbas, III and Julia Gavrilyuk. These collaborations have contributed to the advancement of research in the field of bioconjugation and related areas.

Conclusion

Hitoshi Ban's innovative work in tyrosine bioconjugation represents a significant advancement in the field of chemistry. His contributions are likely to have a lasting impact on peptide and protein modification techniques.